Attenzione! I contenuti di questa pagina sono disponibili solo nelle seguenti lingue: Inglese
There is an alternative to cleanrooms to increase manufacturing capacity
Continuing research into ATPMs (Advanced Therapy Medicinal Products) based on genes, cells or tissues, has increased the number and size of cell factories around the world.
Massimiliano Cesarini presented our vision to address these challenges during the Cell & Gene Therapy World 2018 event held in Miami, Florida.
His talk can be summarized with these 3 points:
- a GMP approach from the beginning is a must
- Isolator technology offers a much more attractive alternative to cleanrooms from a quality and cost standpoint
- Comecer’s FlexyCult™ modular incubation system is game change in cell culture
If you were not present, you can still see his slides below, which include some examples of customers around the world that are implementing our approach.
To request a copy of this presentation, please fill out the form below:
